Millennium Management
IMVT icon

Millennium Management’s Immunovant IMVT Stock Holding History

Millennium Management’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-172,496
Closed -$4.38M – 6015
2025
Q4 		$4.38M Buy
172,496
+84,382
+96% +$1.88M ﹤0.01% 3162
2025
Q3 		$1.42M Sell
88,114
-113,058
-56% -$1.83M ﹤0.01% 4343
2025
Q2 		$3.22M Buy
201,172
+47,932
+31% +$725K ﹤0.01% 3430
2025
Q1 		$2.62M Buy
153,240
+6,143
+4% +$129K ﹤0.01% 3517
2024
Q4 		$3.64M Sell
147,097
-229,410
-61% -$6.51M ﹤0.01% 3121
2024
Q3 		$10.7M Buy
376,507
+101,155
+37% +$2.98M 0.01% 2138
2024
Q2 		$7.27M Sell
275,352
-183,675
-40% -$5.22M ﹤0.01% 2362
2024
Q1 		$14.8M Sell
459,027
-212,374
-32% -$7.75M 0.01% 1812
2023
Q4 		$28.3M Buy
671,401
+12,769
+2% +$470K 0.01% 1247
2023
Q3 		$25.3M Buy
658,632
+109,486
+20% +$2.47M 0.01% 1233
2023
Q2 		$10.4M Sell
549,146
-533,756
-49% -$9.95M 0.01% 1979
2023
Q1 		$16.8M Buy
1,082,902
+1,000,461
+1,214% +$17.4M 0.01% 1475
2022
Q4 		$1.46M Sell
82,441
-162,816
-66% -$2.05M ﹤0.01% 3826
2022
Q3 		$1.37M Sell
245,257
-88,296
-26% -$432K ﹤0.01% 4070
2022
Q2 		$1.3M Sell
333,553
-262,727
-44% -$1.13M ﹤0.01% 4129
2022
Q1 		$3.29M Buy
596,280
+258,312
+76% +$1.61M ﹤0.01% 3416
2021
Q4 		$2.88M Buy
337,968
+130,042
+63% +$1.07M ﹤0.01% 3421
2021
Q3 		$1.81M Sell
207,926
-288,497
-58% -$2.6M ﹤0.01% 4045
2021
Q2 		$5.25M Buy
496,423
+66,461
+15% +$928K ﹤0.01% 2692
2021
Q1 		$6.9M Buy
429,962
+8,778
+2% +$231K ﹤0.01% 2222
2020
Q4 		$19.5M Sell
421,184
-152,279
-27% -$7.04M 0.01% 1089
2020
Q3 		$20.2K Buy
573,463
+116,329
+25% +$3.5M 0.02% 796
2020
Q2 		$11.1M Buy
457,134
+58
+0% +$1.24K 0.02% 1142
2020
Q1 		$7.11M Buy
+457,076
New +$6.88M 0.02% 1083

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Millennium Management's IMVT Position: Q1 2026 in Review

Millennium Management sold out of Immunovant (IMVT) in Q1 2026, closing a stake of 172,496 shares — an estimated $4.38M sold.

Millennium Management first reported a position in IMVT in Q1 2020 and held it in 24 quarters. The position peaked at $28.3M in Q4 2023. 215 funds tracked by Wall St. Rank hold IMVT as of Q1 2026.

  • Millennium Management reported no remaining Immunovant position as of Q1 2026 after selling out during the quarter.
  • Millennium Management sold 172,496 Immunovant shares in Q1 2026, an estimated $4.38M.
  • Millennium Management first reported a position in Immunovant in Q1 2020 and held it in 24 quarters.
  • Millennium Management's Immunovant position peaked at $28.3M in Q4 2023.
  • 215 funds tracked by Wall St. Rank held Immunovant as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.